Biospace med mentioned today that a recent study, a clinical trial included 50-patient, showed that the ultra-low-dose 2D/3D imaging system, EOS, from Biospace offered "significantly better" image quality when compared to CR (Computed Radiography) x-ray system. The study also noted that EOS "substantially reducing patient's dose exposure (of radiation)" by up to 9 times when compared with CR. The study was published in the medical journal Spine.
The study was carried out under the supervision of principal investigator Stefan Parent, M.D., Ph.D., Centre Hospitalier Universitaire Sainte-Justine, Montreal. It was involving 50 patients suffering from spine deformity. All patients had a CR and an EOS examination, while skin dose was measured at skin level in 13 anatomical areas. Image quality was evaluated the results reported that nearly 97% of images were regarded good or better when using EOS. Moreover, the radiation dose was reduced when using EOS other than CR.
Dr. Marie Meynadier, CEO of biospace med, commented saying "Publication of this landmark study in the preeminent medical journal, Spine, is a key step in recognizing the value of our outstanding EOS technology in providing a solution to the issue of medical irradiation. It will fortify our efforts to further establish this revolutionary musculoskeletal imaging modality as a standard of care in orthopedic imaging," she added "EOS is a significant step in the application of the ALARA ("As Low As Reasonably Achievable") principle for dose reduction,"
EOS was designed mainly for diagnosis and follow-up of degenerative diseases and bone and joint deformities. The system offers ultra-low-dose imaging either of whole body or certain spot. EOS produces 3D images of the human skeleton using software that reconstructs the bones of the patient from just two simultaneous images.